clofarabine has been researched along with tosedostat in 1 studies
| Studies (clofarabine) | Trials (clofarabine) | Recent Studies (post-2010) (clofarabine) | Studies (tosedostat) | Trials (tosedostat) | Recent Studies (post-2010) (tosedostat) |
|---|---|---|---|---|---|
| 424 | 101 | 280 | 33 | 7 | 27 |
| Protein | Taxonomy | clofarabine (IC50) | tosedostat (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.19 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 1.5 | |
| Aminopeptidase N | Homo sapiens (human) | 0.68 | |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 0.26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szer, J | 1 |
1 review(s) available for clofarabine and tosedostat
| Article | Year |
|---|---|
The prevalent predicament of relapsed acute myeloid leukemia.
Topics: Adenine Nucleotides; Adult; Aged; Aminoglycosides; Antibodies, Monoclonal, Humanized; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Decision Making; DNA Methylation; fms-Like Tyrosine Kinase 3; Gemtuzumab; Glycine; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Recurrence; Remission Induction; Risk Factors; Salvage Therapy; Stem Cell Transplantation; TOR Serine-Threonine Kinases; Transplantation, Homologous | 2012 |